Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer. Forde PM, Spicer J, Lu S, Provencio M, et al. N Engl J Med 2022 Apr 11. doi: 10.1056/NEJMoa2202170.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Forde PM, Spicer J, Lu S, Provencio M, et al. Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer. N Engl J Med 2022 Apr 11. doi: 10.1056/NEJMoa2202170.
PMID: 35403841